Encompass Health Corp Segments Disclosure
| For the Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Net operating revenues | $ | 5,935.2 | $ | 5,373.2 | $ | 4,801.2 | |||||||||||
| Less: | |||||||||||||||||
| Salaries and benefits | 3,115.9 | 2,901.0 | 2,600.1 | ||||||||||||||
| Other operating expenses | 886.0 | 785.2 | 709.3 | ||||||||||||||
| Supplies | 254.4 | 239.0 | 218.3 | ||||||||||||||
| Occupancy costs | 59.0 | 57.3 | 56.3 | ||||||||||||||
| General and administrative expenses | 173.8 | 156.1 | 146.5 | ||||||||||||||
| Net income attributable to noncontrolling interests | 192.9 | 148.2 | 113.2 | ||||||||||||||
Other segment items(1) | (14.7) | (17.3) | (13.6) | ||||||||||||||
| Adjusted EBITDA | $ | 1,267.9 | $ | 1,103.7 | $ | 971.1 | |||||||||||
| For the Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Adjusted EBITDA | $ | 1,267.9 | $ | 1,103.7 | $ | 971.1 | |||||||||||
| Stock-based compensation | (56.5) | (48.3) | (50.6) | ||||||||||||||
| Depreciation and amortization | (327.9) | (299.6) | (273.9) | ||||||||||||||
| Loss on disposal or impairment of assets | (2.7) | (17.4) | (9.8) | ||||||||||||||
| Loss on early extinguishment of debt | — | (0.6) | — | ||||||||||||||
| Interest expense and amortization of debt discounts and fees | (123.2) | (137.4) | (143.5) | ||||||||||||||
| Net income attributable to noncontrolling interests | 192.9 | 140.9 | 111.0 | ||||||||||||||
| Change in fair market value of marketable securities | 2.5 | 1.0 | 0.7 | ||||||||||||||
| Asset impairment impact on noncontrolling interests | — | 7.3 | — | ||||||||||||||
| State regulatory change impact on noncontrolling interests | — | — | 2.2 | ||||||||||||||
| Income from continuing operations before income tax expense | $ | 953.0 | $ | 749.6 | $ | 607.2 | |||||||||||
| For the Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Net operating revenues: | |||||||||||||||||
| Inpatient | $ | 5,756.3 | $ | 5,230.5 | $ | 4,693.8 | |||||||||||
| Other | 178.9 | 142.7 | 107.4 | ||||||||||||||
| Net operating revenues | $ | 5,935.2 | $ | 5,373.2 | $ | 4,801.2 | |||||||||||
Want the next Encompass Health Corp segments disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Encompass Health Corp's next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Feb 28, 2025 | |
| 2021 | Feb 25, 2022 | |
| 2020 | Feb 26, 2021 | |
| 2019 | Feb 27, 2020 | |
| 2018 | Feb 27, 2019 | |
| 2017 | Feb 28, 2018 | |
| 2016 | Feb 22, 2017 | |
| 2015 | Feb 25, 2016 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.